Pliant Therapeutics PLRX
NASDAQ PLRX
$0.78 -0.02 (-2.83%)
As of: Nov 10, 2026 · 2:59 PM EST

Pliant Therapeutics (PLRX) EV to CFO (2020)

Updated

Pliant Therapeutics' (PLRX) EV to CFO came in at 31.91 for Q3 2020, up 531.4% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) EV to CFO (2020) Analysis & Trends

For the trailing twelve months through Sep 30, 2020, EV to CFO at Pliant Therapeutics was 50.34.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Pliant Therapeutics 50.15 Mn -711.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 31.91
Jun 30, 2020 5.05
API Access

Pliant Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=PLRX&period=max&api_key=YOUR_API_KEY